Determination of the structure of DNA by James Watson and Francis Crick in 1953 followed by the completion of human genome project in 2003 revolutionized the field of medicine and has greatly improved our understanding of cancer.

Cancer is a genomic disease. Cancer develops over many years by the accumulation of mutations in key genes referred to as oncogenes. Scientists have now discovered hundreds of oncogenes, and hundreds more will soon be discovered. A typical human cancer is driven by approximately 5 to 10 different oncogenes. Every human cancer can be defined by its oncogenes signature.

Cancer drugs are most effective when they target activated oncogenes and matching the right drug to the right target in the right patient is critical for a positive outcome. The future of molecular oncology depends on the ability to diagnose the oncogenes signature in individual cancer patient.

ITOS Oncology is dedicated to bring the scientific breakthroughs and the technological advances to the patients at the state-of-the-art facility using the Next Generation Sequencing platform from Illumina.